SAN RAMON, Calif., June 3, 2021—Two key pillars of CooperVision’s industry leadership, its myopia management and 1 Day brand teams, have recently expanded following the hiring of Kamela Bearlin as Senior Global Brand Director, 1 Day Brands, and Jennifer Lambert as Senior Global Brand Director, Myopia Management, and the promotion of Elizabeth Lumb, BSc(Hons) MCOptom, FBCLA, to Director of Global Professional Affairs, Myopia Management.
“Myopia management and 1 Day represent our fastest-growing, highest-opportunity brands,” said Simon Seshadri, Senior Vice President, Global Marketing. “By investing in top talent, we’re moving forward at full speed to continuously grow our strong leadership and investment in these areas.”
As Senior Global Brand Director, 1 Day brands, Kamela Bearlin works with regional commercial teams to grow the CooperVision wearer base and support market-leading growth through the company’s rapidly accelerating 1 Day silicone hydrogel portfolio. Building on the successes of the MyDay® daily disposable and clariti® 1 day families, Bearlin will also support continuous innovation on a global level.
Bearlin is based in Seattle, Washington, and brings over 15 years of global marketing experience with B2C and B2B2C brands, such as Philips Sonicare and Cadbury-Schweppes. Most recently, she spent eight years building her own marketing consultancy through which she built category knowledge with CooperVision as one of her clients. Bearlin holds a Bachelor of Science in Psychology from the University of Washington and completed a post-graduate Honors program at the University of Melbourne.
As Senior Global Brand Director, Myopia Management, Jennifer Lambert works with CooperVision’s global and regional teams to expand its Brilliant Futures™ Myopia Management Program worldwide. This includes launching the program in markets where the lens alone is already available to support the best possible outcomes for age-appropriate* children with myopia. She will also advance a product roadmap that supports future growth in the myopia management category.
Lambert is based in Rochester, New York, and brings more than two decades of marketing experience from her most recent position as Vice President of Global Marketing at The HydraFacial Company and from past roles at Bausch + Lomb, Velocity Outdoor, PepsiCo, and Sun Products. Jennifer received her bachelor’s and master’s degrees in Advertising from The University of Illinois at Urbana-Champaign and an MBA from the University of Connecticut School of Business.
Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA
As Director of Global Professional Affairs, Myopia Management, Elizabeth Lumb works closely with CooperVision’s regional marketing and professional affairs teams to support the ongoing commercialization of the Brilliant Futures™ Myopia Management Program, including MiSight® 1 day and the recently acquired SightGlass Vision™ technology.
Lumb is based in Manchester, United Kingdom. She has been part of the CooperVision team since 2015 and previously led MiSight® 1 day’s rollout in Europe. Through key publications and conferences, Lumb has also driven heightened awareness of myopia management science. She is an optometrist with a first class honors degree from The University of Manchester and a Fellow of the British Contact Lens Association.
“We’re changing the game in the fight against the myopia epidemic with each new market that the Brilliant Futures™ program and MiSight® 1 day contact lenses enter,” said Gary Orsborn, OD, MS, FAAO, FBCLA, Vice President, Global Professional, Medical and Clinical Affairs, CooperVision. “Our myopia management team’s latest additions fuel this momentum in advancing care for children with myopia worldwide.”
# # #
*U.S. Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Hannah Barry, Associate Counselor, McDougall Communications
email@example.com or +1 (585) 645-8985